Carnide E M, Jacob C M, Pastorino A C, Bellinati-Pires R, Costa M B, Grumach A S
Department of Pediatrics, Faculdade de Medicina, Universidade de São Paulo, Brazil.
Sao Paulo Med J. 1998 Nov-Dec;116(6):1873-8. doi: 10.1590/s1516-31801998000600008.
Chédiak-Higashi Syndrome (CHS) is a rare autosomal recessive disease characterized by recurrent infections, giant cytoplasmic granules, and oculocutaneous albinism.
To describe clinical and laboratory findings from CHS patients.
Case report.
The patients were admitted into the Allergy and Immunology Unit of the Instituto da Criança, a tertiary public care institution.
Seven patients had oculocutaneous albinism, recurrent infections and giant cytoplasmic granules in the leukocytes. One patient had low IgG levels and three showed impaired bactericidal activity of neutrophils. Six patients died of infectious complications during the accelerated phase. Therapy included ascorbic acid and antibiotics. Chemotherapy was used for the accelerated phase in two patients. Bone marrow transplantation (BMT) was proposed for one patient.
The authors emphasize the need for early diagnosis and therapy of CHS. BMT should be indicated before the accelerated phase of the disease has developed.
切迪阿克-东综合征(CHS)是一种罕见的常染色体隐性疾病,其特征为反复感染、巨大细胞质颗粒和眼皮肤白化病。
描述CHS患者的临床和实验室检查结果。
病例报告。
患者被收治于一家三级公共医疗机构儿童研究所的过敏与免疫科。
7例患者有眼皮肤白化病、反复感染以及白细胞中的巨大细胞质颗粒。1例患者免疫球蛋白G水平较低,3例患者中性粒细胞杀菌活性受损。6例患者在加速期死于感染性并发症。治疗包括使用抗坏血酸和抗生素。2例患者在加速期使用了化疗。为1例患者提议进行骨髓移植(BMT)。
作者强调对CHS进行早期诊断和治疗的必要性。应在疾病加速期出现之前就考虑进行BMT。